Authors: ROUTLEDGE C GURLING J ASHWORTHPREECE MA DOURISH CT

Citation: C. Routledge et al., DIFFERENTIAL-EFFECTS OF WAY-100135 ON THE DECREASE IN 5-HYDROXYTRYPTAMINE RELEASE INDUCED BY BUSPIRONE AND NAN-190, European journal of pharmacology, 276(3), 1995, pp. 281-284

Authors: ROUTLEDGE C HARTLEY J GURLING J ASHWORTHPREECE M BROWN G DOURISH CT

Citation: C. Routledge et al., IN-VIVO CHARACTERIZATION OF THE PUTATIVE 5-HT1A RECEPTOR ANTAGONIST SDZ-216,525 USING 2 MODELS OF SOMATODENDRITIC 5-HT1A RECEPTOR FUNCTION, Neuropharmacology, 33(3-4), 1994, pp. 359-366

Authors: GURLING J ASHWORTHPREECE MA DOURISH CT ROUTLEDGE C

Citation: J. Gurling et al., EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH THE SELECTIVE 5-HT1A RECEPTOR ANTAGONIST WAY-100635 ON HIPPOCAMPAL 5-HT RELEASE IN-VIVO, British Journal of Pharmacology, 112, 1994, pp. 210000152-210000152

Authors: ROUTLEDGE C GURLING J WRIGHT IK DOURISH CT

Citation: C. Routledge et al., NEUROCHEMICAL PROFILE OF THE SELECTIVE AND SILENT 5-HT(1A) RECEPTOR ANTAGONIST WAY100135 - AN IN-VIVO MICRODIALYSIS STUDY, European journal of pharmacology, 239(1-3), 1993, pp. 195-202